Evidence map›Paper›PMID 39260086›Full record

Trial reportJournal of geriatric oncology2024

Associations of quality of social support and accurate beliefs about curability among older adults with advanced cancer.

Lee A Kehoe, Michael B Sohn, Lu Wang, Supriya Mohile, Charles Kamen, Kim Van Orden, Megan Wells, Nikesha Gilmore, Evelyn Arana-Chicas, Abdi Gudina and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of geriatric oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lee A KehoeJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Division of Supportive Care in Cancer, Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Roybal Center for Social Ties and Aging, Aging Institute, University of Rochester, Rochester, NY, United States of America; Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, United States of America. Electronic address: lee_kehoe@urmc.rochester.edu.
Michael B SohnDepartment of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: Michael_sohn@urmc.rochester.ed.
Lu WangDepartment of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: lu_wang@urmc.rochester.edu.
Supriya MohileJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Division of Hematology/Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: Supriya_mohile@urmc.rochester.edu.
Charles KamenJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Division of Supportive Care in Cancer, Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: Charles_kamen@urmc.rochester.edu.
Kim Van OrdenRoybal Center for Social Ties and Aging, Aging Institute, University of Rochester, Rochester, NY, United States of America; Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, United States of America; Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: Kim_vanorden@urmc.rochester.edu.
Megan WellsJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: megan_wells@urmc.rochester.edu.
Nikesha GilmoreJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Division of Supportive Care in Cancer, Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: Nikesha_gilmore@urmc.rochester.edu.
Evelyn Arana-ChicasDivision of Supportive Care in Cancer, Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Division of Medical Oncology, Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ, United States of America. Electronic address: earana@cinj.rutgers.edu.
Abdi GudinaJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Division of Supportive Care in Cancer, Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: abdi_gudina@urmc.rochester.edu.
Sule YilmezDivision of Supportive Care in Cancer, Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: sule_yilmez@urmc.rochester.edu.
Lorraine GriggsStakeholders for Care in Oncology and Research for our Elders, Rochester, NY, United States of America. Electronic address: lmgriggs@rochester.rr.com.
Kah Poh LohJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Division of Hematology/Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: kahpoh_loh@urmc.rochester.edu.

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Institutional Career Development CoreKL2TR001999 · NCATS · UNIVERSITY OF ROCHESTER · PI XIAO, JIN · 2016 to 2024
$5.2M
Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7M
A Patient-Oriented Research Program in Geriatric OncologyK24AG056589 · NIA · UNIVERSITY OF ROCHESTER · PI Supriya G. Mohile · 2018 to 2026
$1.5M
A novel mobile health exercise intervention for older patients with myeloid neoplasmsR00CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2021 to 2023
$747k
A Phase II Randomized Placebo Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Physical Frailty and Tumor Necrosis Factor-alpha and Associated Immune Markers in Older Cancer SurvivorsK01CA276257 · NCI · UNIVERSITY OF ROCHESTER · PI Nikesha Gilmore · 2023 to 2026
$674k
NCATS NIH HHS KL2 TR001999NCI NIH HHS K01 CA276257NCI NIH HHS R00 CA237744NCI NIH HHS T32 CA102618NCI NIH HHS UG1 CA189961NIA NIH HHS K24 AG056589
6 · The paper itself

Abstract

introductionSupporting older adults with advanced cancer to better understand their disease and its prognosis is important for shared decision-making. Social support is a potentially modifiable factor that may influence disease understanding. In this study, we examined the associations of quantity and quality of social support with patients' beliefs about the curability of their advanced cancer. MATERIALS AND

methodsWe performed a secondary analysis of a cluster-randomized trial that recruited older adults aged ≥70 with advanced incurable cancer. At enrollment, patients completed the Older Americans Resources and Services (OARS) Medical Social Support form that measures both quantity (number of close friends and relatives) and quality of social support. Quality of social support was measured using 12 questions in instrumental and emotional support, each ranging from 1 (none of the time) to 5 (all of the time). Higher cumulative scores indicated greater quality of support. For beliefs about curability, patients were asked, "What do you believe are the chances that your cancer will go away and never come back with treatment?" Responses were 0 %, <50 %, 50/50, >50 %, and 100 %. Ordinal logistic regression was used to investigate the association of quantity and quality of social support with beliefs about curability, adjusting for potential confounders.

resultsWe included 347 patients; mean age was 76.4 years and 91 % were white. Quantity of social support was not associated with belief in curability [adjusted odds ratio (AOR) 1.03, 95 % confidence interval (CI) (0.92, 1.16)]. For every unit increase in the quality of social support (OARS Medical Social Support score), the odds of believing in curability decreased by 26.7 % [AOR 0.73, 95 % CI (0.56, 0.97)]. DISCUSSION: Our study demonstrated that the quality, but not the quantity, of social support was associated with patients' beliefs about curability. These findings suggest that bolstering social support may directly enhance disease understanding. This insight informs supportive care interventions that specifically address disease comprehension among patients.

Indexed as

NeoplasmsSocial SupportAgedAged, 80 and overDecision MakingFemaleHealth Knowledge, Attitudes, PracticeHumansMaleAdvanced cancerGeriatric oncologyPrognostic understandingSocial support

Identifiers

PMID39260086
PMCPMC11869943

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.